Marker Therapeutics Inc (MRKR)

[Rkmatters]

This is definitely a long term hold for me as well. They could very well receive Orphan Drug Status, and be Fast Tracked. According to the company -- whose executives have vast clinical and regulatory experience -- they plan to submit an application. Who knows the timeline on such applications, but obviously that would propel the company to new heights. A definite collaboration and M&A target. Only drawback is the volatility, but the entry and market cap is low at this point.

GLTUA